Skip to content

Procedural Outcomes of Percutaneous PDA Closure: Comparative Study Between Different Devices.

Procedural Outcomes of Percutaneous PDA Closure: Comparative Study Between Different Devices.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04303793
Enrollment
100
Registered
2020-03-11
Start date
2020-06-01
Completion date
2022-06-30
Last updated
2020-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Brief summary

To compare safety, efficacy and procedural outcome of percutaneous PDA closure using different approaches for better characterization of device selection criteria.

Interventions

DEVICEPercutaneous PDA closure

transcatheter patent ductus arteriosus closure

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 70 Years
Healthy volunteers
No

Inclusion criteria

* all patients who are candidate for transcatheter PDA closure

Exclusion criteria

1. Patients with PDA dependent pulmonary circulation. 2. Patients with small sized PDA which is silent by auscultation 3. Patients with large sized PDA which is unsuitable for Trans-catheter closure 4. Patients with PDA and severe irreversible pulmonary hypertension (Eisenmenger's syndrome) (7). 5. Patients with active infection or active infective endarteritis. 6. Patients refusing the study.

Design outcomes

Primary

MeasureTime frameDescription
Procedural safetyone monthstudying the occurrence of catheter related complications including 1. Occurrence of vascular access hematoma(Yes/No ) 2. Occurrence of contrast induced nephropathy (Yes/No) 3. PDA closure Device embolization (Yes/No) 4. Cardiac tamponade (Yes/No)
Procedural efficacyone monthtiming of complete closure of the PDA with no residual shunts 1. Residual left to right shunt (Yes/No) 2. Degree of the residual shunt (Trace, Mild , Moderate, severe) 3. Timing of closure of the shunt( immediately postprocedural, 24 hours post procedural , 1 month post procedural )
Procedural outcomesone monthcomparison of echocardiography data that will be done pre catheter closure, one day post procedure and one month later ( left ventricular and atrial dimensions-left ventricular ejection fraction-pulmonary artery systolic pressure- degree of tricuspid regurge)

Contacts

Primary ContactAhmed Mohamed Moheb El-Din
ahmedmoheb34567@gmail.com01060964666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026